Increased L-arginine transport in human erythrocytes in chronic heart failure

Clinical Science

Volumn 94, Issue 1, 1998, Pages 43-48

  Hanssen, H ^a   Brunini, T M C ^a   Conway, M ^b   Banning, A P ^b   Roberts, N B ^c   Mann, G E ^d   Ellory, J C ^a   Mendes Ribeiro, A C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arginine transport; Erythrocytes; Heart failure; Plasma arginine; Plasma L NMMA

Indexed keywords

ALANINE; ARGININE; ARGININE DERIVATIVE; CITRULLINE; LEUCINE; LYSINE; N ETHYLMALEIMIDE; N(G) METHYLARGININE; NITRIC OXIDE; ORNITHINE;

AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031985243     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940043     Document Type: Article

References (25)

1. Packer M. Pathophysotogy of chronic heart failure. Lancet 1992; 340: 88-92
2. Davies CH, Harding SE, Poole-Wilson PA. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J 1996; 17: 189-98.
3. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JGF. Enhanced basal nitric oxide production in heart failure: another failed counter regulatory vasodilator mechanism. Lancet 1994; 344: 371-2.
4. Noll G, Wenzel RR, Luscher TF. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease. Mol Cell Biochem 1996; 157: 259-67.
5. Drexler H, Hornig B. Importance of endothelial function in chronic heart failure. J Cardiovasc Pharmacol 1996, 27 (Suppl. 2): S9-12.
6. MacAllister RJ, Fickling SA, Whitley GSJ, Vallance P. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 1994; 112: 43-6.
7. Bogle RG, Moncada S, Pearson JD, Mann GE. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 1992; 105: 768-70.
8. Mendes Ribeiro AC, Roberts NB, Lane C, Yaqoob M, Ellory JC. Accumulation of the nitric oxide antagonist N-monomethyl-L-arginine in end stage renal failure patients on regular haemodialysis. Exp Physiol 1996; 81: 475-81.
9. Mendes Ribeiro AC, Kiessling K, Luo LY, Mann GE, Ellory JC. N-monomethyl-L-arginine (L-NMMA) transport in red cells from uraemic patients. J Physiol 1995; 487P: 98P.
10. Mendes Ribeiro AC, Hanssen H, Kiessling K, Roberts NB, Mann GE, Ellory JC. Transport of L-arginine and the nitric oxide inhibitor L-NMMA in human red blood cells in chronic renal failure. Clin Sci 1997; 93: 57-64.
11. Noris M, Benigni A, Boccardo P, et al. Enhanced nitric oxide synthesis in uraemia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44: 445-50.
12. Welt LG, Sachs JR, McManus TJ. An ion transport defect from uremic patients. Trans Assoc Am Phys 1964; 77: 169-81.
13. Bogle RG, Baydoun AR, Pearson JD, Mann GE. L-Arginine transport is increased in macrophages generating nitric oxide. Biochem J 1992; 284: 15-18.
14. Deves R, Angelo S, Chavez P. N-ethylmaleimide discriminates between two lysine transport systems in human erythrocytes. J Physiol 1993; 468: 753-66.
15. MacLeod CL, Kakuda DK. Regulation of CAT: cationic amino acid transporter gene expression. Amino Acids 1996; 11: 171-91.
16. Palacin M. A new family of proteins (rBAT and 4F2hc) involved in cationic and zwitteronic amino acid transport: a tale of two proteins in search of a transport function. J Exp Biol 1994; 196: 124-37.
17. Fervenza FC, Harvey C M, Hendry BM, Ellory JC. Increased lysine transport capacity in erythrocytes from patients with chronic renal failure. Clin Sci 1989; 76: 419-22.
18. Peek K, Roberts NB, Taylor WH. Urinary amino acids: determination of the orthophthalaldehyde derivatives by reverse phase HPLC. Ann Clin Biochem 1988; 25 (Suppl.): 70-3S.
19. Hung J, Harris PJ, Uren RF, Tiller DJ, Kelly DT. Uremic cardiomyopathy: effect of hemodiatysis on left ventricular function in end stage renal failure. N Engl J Med 1980; 302: 547-51.
20. Morgan AJ. Chronic renal failure. In: Marsh FP, ed. Postgraduate nephrotogy. London: William Heineman Medical Books Ltd, 1986: 1901-43.
21. Balligand JL, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993; 91: 2314-19.
22. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and NO production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 1996; 271: 11694-702.
23. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Acta 1991; 180: 926-32.
24. Bogle RG, Baydoun AR, Pearson JD, Mann GE. Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells. J Physiol 1996; 490: 229-41.
25. Chen S, Boyd CAR. Regulation of rat alveolar macrophage nitric oxide (NO) production by cationic amino acid transport. J Physiol 1995; 482P: 44P.